Distinguishing vaccine efficacy and effectiveness

Vaccine

Volumn 30, Issue 47, 2012, Pages 6700-6705

  Shim, Eunha ^a,b   Galvani, Alison P ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Effectiveness; Efficacy; Infectious disease; Mathematical model; Parameterization; Vaccine

Indexed keywords

INFLUENZA VACCINE; MEASLES VACCINE;

ARTICLE; DRUG EFFICACY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MATHEMATICAL MODEL; MEASLES; MEASLES VACCINATION; POPULATION RESEARCH; PRIORITY JOURNAL;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MASS VACCINATION; MEASLES; MEASLES VACCINE; MODELS, THEORETICAL; POPULATION DYNAMICS;

EID: 84867442230     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.045     Document Type: Article

References (29)

1. Haber M. Estimation of the direct and indirect effects of vaccination. Stat Med 1999, 18(August (16)):2101-2109.
2. Haber M., Longini I.M., Halloran M.E. Measures of the effects of vaccination in a randomly mixing population. Int J Epidemiol 1991, 20(March (1)):300-310.
3. Halloran M.E., Struchiner C.J., Longini I.M. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 1997, 146(November (10)):789-803.
4. Halloran M.E., Longini I.M., Struchiner C.J. Design and interpretation of vaccine field studies. Epidemiol Rev 1999, 21(1):73-88.
5. Halloran M.E., Longini I.M., Struchiner C.J. Assessing indirect, total and overall effects. Design and analysis of vaccine studies 2009, Springer, New York.
6. Halloran M.E. Overview of vaccine field studies: types of effects and designs. J Biopharm Stat 2006, 16(4):415-427.
7. Edmunds W.J., Medley G.F., Nokes D.J. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med 1999, 18(December (23)):3263-3282.
8. Brisson M., Edmunds W.J. Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making 2003, 23(January-February (1)):76-82.
9. Smith P.G., Rodrigues L.C., Fine P.E. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984, 13(March (1)):87-93.
10. Shim E., Galvani A.P. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine 2009, 27(June (30)):4025-4030.
11. Shim E., Feng Z., Martcheva M., Castillo-Chavez C. An age-structured epidemic model of rotavirus with vaccination. J Math Biol 2006, 53(October (4)):719-746.
12. Kribs-Zaleta C.M., Velasco-Hernandez J.X. A simple vaccination model with multiple endemic states. Math Biosci 2000, 164(April (2)):183-201.
13. Shim E. A note on epidemic models with infective immigrants and vaccination. Math Biosci Eng 2006, 3(3):557-566.
14. Arino J., Cooke K.L., van den Driessche P., Velasco-Hernández J. An epidemiology model that includes a leaky vaccine with a general waning function. Discr Contin Dynam Syst - Ser B 2004, 4(2):479-495.
15. Anderson R., May R. Infectious diseases of humans: dynamics and control 1991, Oxford University Press, New York, See p. 311, Eq. (12.23) and discussion.
16. White M.T., Griffin J.T., Drakeley C.J., Ghani A.C. Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. Malaria J 2010, 9:82.
17. Ball F.G., Lyne O.D. Optimal vaccination policies for stochastic epidemics among a population of households. Math Biosci 2002, 177-178(May-June):333-354.
18. Keeling M.J., Shattock A. Optimal but unequitable prophylactic distribution of vaccine. Epidemics 2012, 4(June (2)):78-85.
19. Ball F., Britton T. An epidemic model with infector and exposure dependent severity. Math Biosci 2009, 218(April (2)):105-120.
20. Lugner A.K., van Boven M., de Vries R., Postma M.J., Wallinga J. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis. BMJ 2012, 345:e4445.
21. Longini I.M., Halloran M.E., Haber M. Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity. Math Biosci 1993, 117(September-October (1-2)):271-281.
22. Ma J., Earn D.J. Generality of the final size formula for an epidemic of a newly invading infectious disease. Bull Math Biol 2006, 68(April 3):679-702.
23. Liu J., Kochin B.F., Tekle Y.I., Galvani A.P. Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. J R Soc Interface 2012, 9(66):68-76.
24. Preziosi M.P., Halloran M.E. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine 2003, 21(May (17-18)):1853-1861.
25. Truscott J., Fraser C., Cauchemez S., Meeyai A., Hinsley W., Donnelly C.A., et al. Essential epidemiological mechanisms underpinning the transmission dynamics of seasonal influenza. J R Soc Interface/the Royal Society 2012, 9(February (67)):304-312.
26. Mori N., Ohkusa Y., Ohyama T., Tanaka-Taya K., Taniguchi K., Kobayashi J.M., et al. Estimation of measles vaccine coverage needed to prevent transmission in schools. Pediatr Int 2008, 50(August (4)):464-468.
27. Strebel P.M., Papania M.J., Fine P.E.M. Measles vaccine, and community immunity. Vaccine 2003, 389-440. WB Saunders, Philadelphia, 1443-61. 4th ed. S. Plotkin, W.A. Orenstein (Eds.).
28. Shim E., Grefenstette J.J., Albert S.M., Cakouros B.E., Burke D.S. A game dynamic model for vaccine skeptics and vaccine believers: measles as an example. J Theor Biol 2011, 295C(November):194-203.
29. Halloran M.E., Struchiner C.J. Study designs for dependent happenings. Epidemiology 1991, 2(September (5)):331-338.